Fisher Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Fisher Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-226,335	Closed	-$2.49M	–	825
2017 Q2	$2.49M	Buy	226,335 +70,712	+45%	+$707K	﹤0.01%	459
2017 Q1	$1.52M	Buy	155,623 +39,406	+34%	+$394K	﹤0.01%	480
2016 Q4	$1.25M	Sell	116,217 -106,610	-48%	-$1.07M	﹤0.01%	485
2016 Q3	$2.28M	Sell	222,827 -75,187	-25%	-$819K	﹤0.01%	448
2016 Q2	$3.99M	Sell	298,014 -161,593	-35%	-$2.12M	0.01%	374
2016 Q1	$5.86M	Sell	459,607 -25,241	-5%	-$224K	0.01%	335
2015 Q4	$4.46M	Buy	484,848 +86,422	+22%	+$723K	0.01%	357
2015 Q3	$2.77M	Buy	+398,426	New	+$3.41M	0.01%	406

Other funds holding SCLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fisher Asset Management's SCLN Position: Q3 2017 in Review

Fisher Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2017, closing a stake of 226,335 shares — an estimated $2.49M sold.

Fisher Asset Management first reported a position in SCLN in Q3 2015 and held it in 8 quarters. The position peaked at $5.86M in Q1 2016. 129 funds tracked by Wall St. Rank hold SCLN as of Q3 2017.

Fisher Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
Fisher Asset Management sold 226,335 Sciclone Pharmaceuticals Inc shares in Q3 2017, an estimated $2.49M.
Fisher Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2015 and held it in 8 quarters.
Fisher Asset Management's Sciclone Pharmaceuticals Inc position peaked at $5.86M in Q1 2016.
129 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2017.

Based on Fisher Asset Management's 13F filing for Q3 2017, filed 17 Oct 2017.